MARGARET DEROSA: Open Payments
NPI 1538612593 · BRANDYWINE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 34 payments from 17 companies in 2025. Trend: 2023 $1,500 · 2024 $1,009 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $130 |
| Janssen Biotech, Inc. | 4 | $86 |
| ABBVIE INC. | 3 | $78 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Novocure Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Stemline Therapeutics Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Incyte Corporation | 2 | $42 |
| PFIZER INC. | 2 | $39 |
Products named: KEYTRUDA, Enhertu, TECVAYLI, IMBRUVICA, Optune Lua (NovoTTF-200T), Orserdu, JAKAFI, XTANDI.
Industry payments across MD — which companies pay providers there.
